Cargando…

Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations

Amorphous molecule-macromolecule mixtures are ubiquitous in polymer technology and are one of the most studied routes for the development of amorphous drug formulations. For these applications it is crucial to understand how the preparation method affects the properties of the mixtures. Here, we emp...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenti, Sofia, del Valle, Luis Javier, Romanini, Michela, Mitjana, Meritxell, Puiggalí, Jordi, Tamarit, Josep Lluís, Macovez, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910109/
https://www.ncbi.nlm.nih.gov/pubmed/35269593
http://dx.doi.org/10.3390/ijms23052456
_version_ 1784666374243614720
author Valenti, Sofia
del Valle, Luis Javier
Romanini, Michela
Mitjana, Meritxell
Puiggalí, Jordi
Tamarit, Josep Lluís
Macovez, Roberto
author_facet Valenti, Sofia
del Valle, Luis Javier
Romanini, Michela
Mitjana, Meritxell
Puiggalí, Jordi
Tamarit, Josep Lluís
Macovez, Roberto
author_sort Valenti, Sofia
collection PubMed
description Amorphous molecule-macromolecule mixtures are ubiquitous in polymer technology and are one of the most studied routes for the development of amorphous drug formulations. For these applications it is crucial to understand how the preparation method affects the properties of the mixtures. Here, we employ differential scanning calorimetry and broadband dielectric spectroscopy to investigate dispersions of a small-molecule drug (the Nordazepam anxiolytic) in biodegradable polylactide, both in the form of solvent-cast films and electrospun microfibres. We show that the dispersion of the same small-molecule compound can have opposite (plasticizing or antiplasticizing) effects on the segmental mobility of a biopolymer depending on preparation method, temperature, and polymer enantiomerism. We compare two different chiral forms of the polymer, namely, the enantiomeric pure, semicrystalline L-polymer (PLLA), and a random, fully amorphous copolymer containing both L and D monomers (PDLLA), both of which have lower glass transition temperature (T(g)) than the drug. While the drug has a weak antiplasticizing effect on the films, consistent with its higher T(g), we find that it actually acts as a plasticizer for the PLLA microfibres, reducing their T(g) by as much as 14 K at 30%-weight drug loading, namely, to a value that is lower than the T(g) of fully amorphous films. The structural relaxation time of the samples similarly depends on chemical composition and morphology. Most mixtures displayed a single structural relaxation, as expected for homogeneous samples. In the PLLA microfibres, the presence of crystalline domains increases the structural relaxation time of the amorphous fraction, while the presence of the drug lowers the structural relaxation time of the (partially stretched) chains in the microfibres, increasing chain mobility well above that of the fully amorphous polymer matrix. Even fully amorphous homogeneous mixtures exhibit two distinct Johari–Goldstein relaxation processes, one for each chemical component. Our findings have important implications for the interpretation of the Johari–Goldstein process as well as for the physical stability and mechanical properties of microfibres with small-molecule additives.
format Online
Article
Text
id pubmed-8910109
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89101092022-03-11 Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations Valenti, Sofia del Valle, Luis Javier Romanini, Michela Mitjana, Meritxell Puiggalí, Jordi Tamarit, Josep Lluís Macovez, Roberto Int J Mol Sci Article Amorphous molecule-macromolecule mixtures are ubiquitous in polymer technology and are one of the most studied routes for the development of amorphous drug formulations. For these applications it is crucial to understand how the preparation method affects the properties of the mixtures. Here, we employ differential scanning calorimetry and broadband dielectric spectroscopy to investigate dispersions of a small-molecule drug (the Nordazepam anxiolytic) in biodegradable polylactide, both in the form of solvent-cast films and electrospun microfibres. We show that the dispersion of the same small-molecule compound can have opposite (plasticizing or antiplasticizing) effects on the segmental mobility of a biopolymer depending on preparation method, temperature, and polymer enantiomerism. We compare two different chiral forms of the polymer, namely, the enantiomeric pure, semicrystalline L-polymer (PLLA), and a random, fully amorphous copolymer containing both L and D monomers (PDLLA), both of which have lower glass transition temperature (T(g)) than the drug. While the drug has a weak antiplasticizing effect on the films, consistent with its higher T(g), we find that it actually acts as a plasticizer for the PLLA microfibres, reducing their T(g) by as much as 14 K at 30%-weight drug loading, namely, to a value that is lower than the T(g) of fully amorphous films. The structural relaxation time of the samples similarly depends on chemical composition and morphology. Most mixtures displayed a single structural relaxation, as expected for homogeneous samples. In the PLLA microfibres, the presence of crystalline domains increases the structural relaxation time of the amorphous fraction, while the presence of the drug lowers the structural relaxation time of the (partially stretched) chains in the microfibres, increasing chain mobility well above that of the fully amorphous polymer matrix. Even fully amorphous homogeneous mixtures exhibit two distinct Johari–Goldstein relaxation processes, one for each chemical component. Our findings have important implications for the interpretation of the Johari–Goldstein process as well as for the physical stability and mechanical properties of microfibres with small-molecule additives. MDPI 2022-02-23 /pmc/articles/PMC8910109/ /pubmed/35269593 http://dx.doi.org/10.3390/ijms23052456 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Valenti, Sofia
del Valle, Luis Javier
Romanini, Michela
Mitjana, Meritxell
Puiggalí, Jordi
Tamarit, Josep Lluís
Macovez, Roberto
Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
title Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
title_full Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
title_fullStr Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
title_full_unstemmed Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
title_short Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
title_sort drug-biopolymer dispersions: morphology- and temperature- dependent (anti)plasticizer effect of the drug and component-specific johari–goldstein relaxations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910109/
https://www.ncbi.nlm.nih.gov/pubmed/35269593
http://dx.doi.org/10.3390/ijms23052456
work_keys_str_mv AT valentisofia drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations
AT delvalleluisjavier drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations
AT romaninimichela drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations
AT mitjanameritxell drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations
AT puiggalijordi drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations
AT tamaritjoseplluis drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations
AT macovezroberto drugbiopolymerdispersionsmorphologyandtemperaturedependentantiplasticizereffectofthedrugandcomponentspecificjoharigoldsteinrelaxations